Stock Market News3 months Alto Neuroscience (NYSE:ANRO) Stock Rating Lowered by Rodman & Renshaw MarketBeat
Rodman & Renshaw lowered Alto Neuroscience from a “buy” rating to a “neutral” rating in a report on Wednesday.
XRodman & Renshaw lowered Alto Neuroscience from a “buy” rating to a “neutral” rating in a report on Wednesday.
X